New weight loss drug IBIO-600 enters first human trial
Disease control
Recruiting now
This early-stage trial tests a single dose of the experimental drug IBIO-600 in 32 overweight or obese adults. The main goal is to see if the drug is safe and tolerable, and to measure how it moves through the body. Researchers will also look at its effect on body composition. Th…
Phase: PHASE1 • Sponsor: iBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC